Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Social Cognition
NCT02393456Phase 1Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jan 2015
- Primary completion
- Jul 2016
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in social cognition disorder, sponsored by University of California, Los Angeles. Primary endpoint: Changes in neural brain activity during social inclusion vs. exclusion. Started Jan 2015; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
social cognition disorder
Beyond the preview
Go deeper on NCT02393456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02393456.